These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 34511991)
41. Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study. Sun Y; Li Z; Tian Y; Gao C; Liang B; Cao S; Liu X; Liu X; Meng C; Xu J; Yang H; Zhou Y BMC Gastroenterol; 2023 Apr; 23(1):117. PubMed ID: 37041468 [TBL] [Abstract][Full Text] [Related]
42. Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis. Yi J; Liu Z; Wang L; Zhang X; Pi L; Zhou C; Mu H Front Oncol; 2022; 12():857375. PubMed ID: 35372011 [TBL] [Abstract][Full Text] [Related]
43. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma. Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459 [TBL] [Abstract][Full Text] [Related]
44. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases. Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507 [TBL] [Abstract][Full Text] [Related]
45. Development and Validation of Prognostic Survival Nomograms for Patients with Anal Canal Cancer: A SEER-Based Study. Tang J; Zhu L; Huang Y; Yang L; Ge D; Hu Z; Wang C Int J Gen Med; 2021; 14():10065-10081. PubMed ID: 34984027 [TBL] [Abstract][Full Text] [Related]
46. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma. Xiao R; Liu C; He W; Ma L Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402 [TBL] [Abstract][Full Text] [Related]
47. Construction and validation of prognostic nomogram for metaplastic breast cancer. Li Y; Chen D; Xuan H; Dragomir MP; Calin GA; Meng X; Chen M; Jin H Bosn J Basic Med Sci; 2022 Feb; 22(1):131-139. PubMed ID: 34247567 [TBL] [Abstract][Full Text] [Related]
48. Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma. Jin H; Feng Y; Guo K; Ruan S Front Oncol; 2020; 10():595354. PubMed ID: 33194760 [TBL] [Abstract][Full Text] [Related]
49. Development and validation of prognostic nomogram for germ cell testicular cancer patients. Mao W; Wu J; Kong Q; Li J; Xu B; Chen M Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554 [TBL] [Abstract][Full Text] [Related]
50. Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study. Li Z; Lin Y; Cheng B; Zhang Q; Cai Y Front Oncol; 2021; 11():651975. PubMed ID: 34336651 [TBL] [Abstract][Full Text] [Related]
51. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer. Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420 [No Abstract] [Full Text] [Related]
52. Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database. Zhang X; Hu Y; Deng K; Ren W; Zhang J; Liu C; Ma B J Cancer Res Clin Oncol; 2023 Nov; 149(15):14057-14070. PubMed ID: 37548772 [TBL] [Abstract][Full Text] [Related]
53. Nomograms for predicting overall survival and cancer-specific survival in young patients with pancreatic cancer in the US based on the SEER database. Shi M; Zhou B; Yang SP PeerJ; 2020; 8():e8958. PubMed ID: 32322444 [TBL] [Abstract][Full Text] [Related]
54. Establishment and validation of a postoperative predictive model for patients with colorectal mucinous adenocarcinoma. Wang P; Song Q; Lu M; Xia Q; Wang Z; Zhao Q; Ma X World J Surg Oncol; 2022 Oct; 20(1):330. PubMed ID: 36192778 [TBL] [Abstract][Full Text] [Related]
55. Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study. Zhou Z; Mo S; Dai W; Xiang W; Han L; Li Q; Wang R; Liu L; Zhang L; Cai S; Cai G Cancer Cell Int; 2019; 19():355. PubMed ID: 31889907 [TBL] [Abstract][Full Text] [Related]
56. Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study. Zhang Z; Zhanghuang C; Wang J; Tian X; Wu X; Li M; Mi T; Liu J; Jin L; Li M; He D Front Oncol; 2022; 12():918780. PubMed ID: 35814387 [TBL] [Abstract][Full Text] [Related]
57. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years. Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294 [TBL] [Abstract][Full Text] [Related]
58. Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection. Chen Q; Chen J; Deng Y; Zhang Y; Huang Z; Zhao H; Cai J J Gastrointest Oncol; 2022 Feb; 13(1):171-184. PubMed ID: 35284104 [TBL] [Abstract][Full Text] [Related]
59. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study. Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017 [TBL] [Abstract][Full Text] [Related]
60. Development and validation of a prognostic nomogram for Hürthle cell thyroid carcinoma: a SEER-based study. Shen C; Zhao Y; Qiu X; Li P; Ding Y; Wang W; Sun B; Li X; Jiang W Gland Surg; 2022 Mar; 11(3):535-544. PubMed ID: 35402212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]